🇺🇸 FDA
Patent

US 10457726

Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

granted A61KA61K2039/505

Quick answer

US patent 10457726 (Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof) held by UNIVERSITY OF CONNECTICUT expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505